0132 GMT - a2 Milk keeps its bull at Macquarie despite a number of uncertainties. Ongoing growth in Chinese sales of English-labeled infant formula, potential benefits from strategic supply chain investment, and the chance of additional capital returns are among the factors sustaining the stock's continued outperform rating from Macquarie analysts. They acknowledge worries including on softening export data and modest ingredient cost pressure, but still see value. They write in a note that they are more conservative than consensus on fiscal 2026 revenue growth forecasts, but slightly more optimistic on earnings margins. Macquarie lifts its target price 5.7% to A$8.30. Shares are up 1.2% at A$8.015. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
July 27, 2025 21:32 ET (01:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.